Department of Anesthesiology, Zhongnan Hospital of Wuhan University, 430071 Wuhan, Hubei, PR China.
Department of Anesthesiology, Zhongnan Hospital of Wuhan University, 430071 Wuhan, Hubei, PR China.
Clin Immunol. 2022 Jun;239:109040. doi: 10.1016/j.clim.2022.109040. Epub 2022 May 13.
Although the mortality rate of sepsis decreases annually, sepsis is still one of the most common causes of death in hospitals. Specific treatments have not been researched yet because of the dynamical pathophysiological process and the individual differences. Most doctors used to treat sepsis by inhibiting inflammation, but the effect of that was not desirable. And many septic patients died of the complications of the second infection in the late period. The sequelae caused by sepsis are inevitable despite most symptoms can be controlled by current advanced therapeutic methods. Some desirable results were obtained from many immunomodulatory methods in some animal experiments and clinical patients, but these therapeutic methods couldn't treat all septic patients yet. Some changes in immune function that occur in each period of sepsis and some corresponding immunomodulatory treatments of sepsis will be introduced in this review.
尽管脓毒症的死亡率逐年下降,但它仍是医院中最常见的死亡原因之一。由于脓毒症病理生理学过程的动态变化和个体差异,目前还没有针对其的具体治疗方法。大多数医生过去常通过抑制炎症来治疗脓毒症,但效果并不理想。而且许多脓毒症患者在后期死于二次感染的并发症。尽管目前先进的治疗方法可以控制大多数症状,但脓毒症引起的后遗症是不可避免的。在一些动物实验和临床患者中,许多免疫调节方法取得了一些令人满意的结果,但这些治疗方法还不能治疗所有的脓毒症患者。本文将介绍脓毒症各期发生的免疫功能变化及相应的免疫调节治疗。